Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)

Spain · Delayed Price · Currency is EUR

84.60

+2.55 (3.11%)

Feb 26, 2026, 5:35 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Manufacturing	600.35M	644.41M	619.23M	471.79M	239.68M
Manufacturing Growth	-6.84%	4.07%	31.25%	96.84%	21.35%
Marketing	427.53M	420.23M	414.15M	383.98M	463.74M
Marketing Growth	1.74%	1.47%	7.86%	-17.20%	18.08%
Inter-Segment Transactions	-264.13M	-235.13M	-215.69M	-207.09M	-283.46M
Total	763.75M	829.51M	817.70M	648.68M	419.96M
Total Growth	-7.93%	1.44%	26.06%	54.46%	10.14%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Spain	277.01M	273.36M	264.27M	256.70M	228.82M
Spain Growth	1.34%	3.44%	2.95%	12.18%	-1.48%
Euro Zone	146.11M	143.65M	136.55M	119.63M	127.21M
Euro Zone Growth	1.71%	5.20%	14.14%	-5.96%	-2.01%
Other Countries	35.87M	31.63M	40.12M	28.79M	14.49M
Other Countries Growth	13.42%	-21.18%	39.36%	98.67%	82.11%
OECD Countries	304.76M	380.88M	376.76M	243.56M	49.44M
OECD Countries Growth	-19.99%	1.09%	54.69%	392.66%	338.89%
Total	763.75M	829.51M	817.70M	648.68M	419.96M
Total Growth	-7.93%	1.44%	26.06%	54.46%	10.14%

Source: S&P Global Market Intelligence.